Filamentous M13 phage can be engineered to display cancer cell-targeting or tumor-homing peptides through phage display. It would be highly desirable if the tumor-targeting phage can also carry anticancer drugs to deliver them to the cancer cells. We studied the evolution of structures of the complexes between anionic filamentous M13 phage and cationic serum-stable liposomes that encapsulate the monomeric photosensitizer zinc naphthalocyanine. At specific phage-liposome ratios, multiple phage nanofibers and liposomes are interwoven into a "nanoweb." The chemical and biological properties of the phage-liposome nanoweb were evaluated for possible application in drug delivery. This study highlights the ability of phage-liposome nanowebs to serve as efficient carriers in the transport of photosensitizers to cancer cells.
Introduction
The use of liposomes for drug delivery across cell membranes is ubiquitous, owing to their biocompatibility, ability to protect encapsulant, and improve circulatory half-life and release profiles (1) (2) (3) . Compared with other cancer therapies, photomedicine, which comprises photothermal therapy (PTT) and photodynamic therapy (PDT), has many advantages, including the absence of toxic side effects or disfigurement (3) . Developments in diode lasers and optical fibers have introduced PTT and PDT as emerging cancer treatment methods. Whereas PTT relies on the ability of electromagnetic radiation to treat cancer cells, PDT takes advantage of the interaction of light with drug (in this case, the photosensitizer) to initiate apoptosis or necrosis of cancer cells and destroy the tumor (1, 4) . In PDT, cytotoxic reactions are initiated by reactive oxygen species generated due to transfer of triplet state energy from photosensitizer to nearby oxygen molecules present when activated by light (5) . The effect of PDT is dependent on the ability of photosensitizer to bring about photooxidation of biological matter through a type I (radical formation through photosensitized electron transfer) or type II (formation of singlet oxygen) mechanism. One of the most promising photosensitizers used in PDT is zinc 2,11,20,29-tetra-tert-butyl-2,3-naphthalocyanine (ZnNC), which has improved properties such as increased tissue penetration arising from strong absorbance at long wavelengths (700-1,000 nm; refs. 6-9). 2,3-Naphthlocyanine has been reported to bring about photonecrosis or random necrosis, with direct photodamage to the membrane, mitochondria, and rough endoplasmic reticulum in the neoplastic cells and delayed photodestruction of the endothelial cells surrounding the tumor tissue (10) (11) (12) . Its phototoxicity is enhanced due to the relatively long-lived excited singlet and triplet states in high quantum yields, and there is nearly 100% increase in singlet oxygen efficiency (13) . However, ZnNC, like most photosensitizers used in PDT, is insoluble in water and tends to aggregate in biologically compatible solvents, which further reduces photosensitizing efficiency and causes low tumor selectivity (14, 15) . The insolubility and aggregation of the drugs can be overcome by encapsulating them inside liposomes (16) . In liposomal media, energy transfer and singlet oxygen formation (type I and type II mechanism) have been found to occur efficiently (17) . However, liposomal structure may be disrupted by serum proteins and biological membranes, resulting in the nonspecific release of photosensitizer into the bloodstream (14, 16) . This drawback and the inability to deliver drugs to target sites can be overcome through chemical or physical modification (18) . Chemical methods include surface coating with polyethylene glycol chains (19) and ligands such as antibodies (20) , peptides (2) , sterol modification (21) , or small molecules (22) . However, incorporating targeting motifs into liposomes has been shown to result in increased leakage of encapsulated drugs (23, 24) .
Here, we show a new drug delivery system in which cationic liposomes (which encapsulate ZnNC) and filamentous M13 phage (which can codisplay anionic peptides and cell-or tissue-specific peptides; Supplementary Scheme S1) are electrostatically assembled into a web-like nanostructure (Fig. 1) . The M13 phage has attracted worldwide attention in medical and materials research (25) . It has the potential for gene transfer, drug delivery, and vaccine delivery due to its plasticity, low cost, stability, and safety (26) (27) (28) . It is a rod-like virus Figure 1 . Filamentous phages, which were genetically engineered to display an anionic peptide on the side wall, were mixed with cationic liposomes that encapsulate ZnNc. As a result, a complex was formed in which phage and liposomes were interwoven into a nanoweb (not to scale).
(∼880-nm long and ∼7-nm wide) that specifically infects bacteria and is nontoxic to humans. Its side wall is assembled from ∼2,700 copies of a major coat protein called pVIII, whereas a few copies of minor coat proteins (e.g., pIII) form the two distal ends of the phage (Supplementary Scheme S1). Because the coat protein is encoded by the DNA encapsulated inside the protein coat, foreign peptides can be displayed on the tip and/or side wall of the phage by genetic means (25, (29) (30) (31) . In this work, we displayed an anionic peptide with a sequence of Glu8 on the side wall of phage to make it anionic (Scheme S1) and encapsulated ZnNC in the hydrophobic region of the lipid bilayers of cationic liposomes. Thus, the anionic phage can electrostatically interact with cationic liposomes to form a novel nanoweb (Fig. 1) for targeted drug delivery through PDT because target-specific peptides can be codisplayed on the phage.
Materials and Methods

Chemicals/materials
MTT, chloramphenicol, dimethylsulfoxide (DMSO), hexadecyltrimethylammonium bromide (CTAB), isopropyl-L-thio-β-D-galactopyranoside, kanamycin, LuriaBertani broth, N-(3-dimethylaminopropyl)-N′-ethyl carbodiimide hydrochloride (EDC), phosphotungstic acid, polyethylene glycol, rhodamine B, sodium chloride, tetracycline, trehalose, Tris, ZnNC, and other minor chemicals were from Sigma-Aldrich, and used without purification. 1,2-Di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-di-(9Z-octadecenoyl)-3-trimethylammonium-propane (chloride salt; DOTAP) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(carboxyfluorescein) (ammonium salt; DOPE-CF), all in chloroform, were from Avanti Polar Lipids, Inc., and used as received. DMEM, McCoy's 5a modified medium, and other cell culture requirements were from the American Type Culture Collection. KSFM was from Invitrogen.
Display of the E8 peptide on the major coat protein, pVIII (i.e., side wall), of the M13 phage
The molecular cloning technique used in this work was done as described in the literature (32) . The phage display technique was used to fuse eight glutamic acid residues (E8) to the NH 2 terminus of the major coat protein of the M13 bacteriophage. By using Escherichia coli XL 1 blue bacteria and pecan49 as a phagemid, the GLU-pecan49 was constructed. For this, pecan49 was digested with NcoI and HindIII restriction endonucleases and ligated with similarly digested GLU-g8p PCR product, which was amplified by PCR of M13K07. The primers used were 5′-ATCCATGGCGGAA-G A A G A A G A A G A A G A A G A A G A A G AT C C C G -CAAAAGCG-3′ (NcoI restriction site is underlined) and 5′-GCAAGCTTTTATCAGCTTGCTTTCGAG-3′ (HindIII restriction site is underlined).
Briefly, the PCR products were purified using QIAgen PCR product purification kit (QIAgen, Inc.) according to the described procedures in the kit. The purified DNA was digested, and the DNA fragments were loaded into 1% agarose gel and isolated by electrophoresis in 0.5× Tris-borate EDTA buffer. The digested fragment was then extracted from the agarose gel using QIAgen gel DNA extraction kit. The ligation reaction was carried out at 25°C for 2 hours using T4 ligase. DNA was then transfected into competent E. coli TG1 cells by using the CaCl 2 method. The transfected bacteria (100 μL) was spread onto agar plate containing 30 μg/mL chloramphenicol and 2% glucose. A well-separated clone from the plate was inoculated into 3 mL Luria-Bertani broth (plus 2% glucose) and incubated at 250 rpm at 37°C overnight. The recombinant phagemid DNA was isolated using QIAgen Miniprep plasmid extraction kit according to the manufacturer's protocols. To analyze the recombinant phagemid DNA, phagemid DNA was digested with both NcoI and HindIII restriction enzymes. The digested products were analyzed by electrophoresis in agarose gel and observed under UV light. The correctly inserted fragments were verified by DNA sequencing (carried out MCLAB). To display E8 on the major coat of the M13 phage, 0.5 μL recombinant phagemid DNA was transfected into competent host strain XL1 blue E. coli by using the CaCl 2 method. The transfected bacteria were spread on an agar plate containing 20 μg/mL tetracycline and 35 μg/mL chloramphenicol. Then, a well-spread clone from the plate was inoculated into 3 mL Luria-Bertani medium containing the appropriate antibiotics. The culture was incubated in the tube for 4 to 6 hours at 37°C with moderate shaking. M13KO7 virions (1.2 × 10 10 plaque-forming units) were added to the tube, and the tube was further incubated for 30 minutes at 37°C. The mixture in the tube was transferred to 150 mL of Luria-Bertani medium containing appropriate antibiotics. Kanamycin was added to reach a final concentration of 70 μg/mL, and isopropyl-L-thio-β-D-galactopyranoside was added to a final concentration of 0.1 mmol/L. The mixture was incubated overnight at 37°C with vigorous shaking.
Engineered phage purification
The overnight culture was first centrifuged at 2,400 × g for 10 minutes at 4°C by using a Beckman Coulter highperformance centrifuge, and the supernatant was collected and recentrifuged at 6,700 × g for 10 minutes at 4°C. Then, one-fifth volume of polyethylene glycol/sodium chloride solution was added, and the suspension was stored in a refrigerator overnight. Phage precipitates were collected by centrifugation at 10,100 × g for 60 minutes at 4°C, dissolved in TBS, and centrifuged at 10,100 × g for 10 minutes until clear. The engineered phage was then examined under a transmission electron microscope (TEM), and its concentration was determined spectrophotometrically (Shimadzu UV2101 PC) by measuring the absorbance at 269 nm.
Preparation of ZnNC-encapsulated liposomes
The liposome was made from a cationic lipid DOTAP and a helper lipid DOPE in a molar ratio of 30:70. A stock solution of ZnNC was prepared in DMSO such that the effective concentration was 6 mmol/L. The two lipids, DOPE (1 g/50 mL) and DOTAP (1 mg/ 4 mL), were procured as chloroform solutions and used as such without purification. The two lipids were mixed in a mole ratio of 70:30 such that the total mole weight of the lipids was 4.10 × 10 −3 g. Six hundred microliters of ZnNC in DMSO were added to the lipid mixture, shaken well, and the chloroform was removed under nitrogen atmosphere in a narrow glass beaker and desiccated under vacuum for 6 hours. Hydration was done using three parts of CTAB for every part of lipid. CTAB stock solution was prepared in PBS [10 mmol/L NaH 2 PO 4 (pH 7.0), 100 mmol/L sodium chloride]. After addition of CTAB, the contents of the flask was vortexed for 3 minutes, allowed to hydrate for about 30 minutes, and finally sonicated to obtain a clear solution. The solution was then subjected to extensive dialysis (dialysis bag MWCO 6,000-8,000 daltons) against phosphate buffer to remove most of the excess CTAB. The dialyzed vesicle suspension was eluted through a Sephadex G-50 column to remove unbound ZnNC, lipids, and surfactant, with phosphate buffer as solvent. The formed multilamellar vesicles were then extruded through a 100-nm-diameter polycarbonate membrane for 21 times to form small unilamellar vesicles. The final suspension (25 mL) was in phosphate buffer and stored in the dark at 4°C. Residual chloroform was analyzed by using gas chromatography.
Preparation of phage-liposome complexes
The concentration of phage used in this study was spectrophotometrically determined as per reported procedures (33) . Liposomes having known lipid concentrations were mixed with varying quantities of engineered phage and made up to 3 mL in phosphate buffer such that the lipid to engineered phage (L/P) weight ratio varied from 2 to 40 for a lipid concentration of 4.92 × 10
mol/L) and engineered phage concentration varying from 0 to 30 × 10 −11 mol/L. After an initial mixing of the solution by vortexing for 30 seconds, the mixture was allowed to stand for 30 minutes in room temperature for the selfassembly of liposomes onto the engineered phage. Subsequently, the phage-liposome complexes were stored in the dark at 4°C for characterization.
Determination of the concentration of ZnNC in liposomes and in the phage-liposome complex
The amount of ZnNC encapsulated was determined spectrophotometerically after disruption of the liposomes in absolute ethanol. The absorbance of the sample after appropriate dilution in DMSO was measured at 769 nm and with an extinction coefficient of 1.08 × 10 5 mol/L/cm (as determined from a standard plot constructed using various concentrations of ZnNC in DMSO). The monomeric nature of ZnNC was confirmed by comparing the UV-Vis spectral characteristics of ZnNC in DMSO, liposome, and the phage-liposome complex.
Charge of liposomes and phage-liposome complexes
The ζ potential of the liposome and phage-liposome complex was measured using Zetapals (Brookhaven Instruments Corporation) and the Hemholtz-Smoluchowski equation.
Size and morphology of liposomes and phage-liposome complexes
Size distribution was measured using dynamic light scattering using a particle sizer (Zetapals, Brookhaven Instruments Corporation). The morphology of the liposomes, engineered phages, and phage-liposome complexes was evaluated under a TEM. For this, 10 μL of the sample were mixed with equal quantity of a negative stain (comprising of 5% phosphotungstic acid and 2.5% trehalose at pH 7.3) on a parafilm, and the resultant solution was dropped onto a formvar-coated 400-mesh copper grid. After 5 minutes, the leftover solution was wicked away and the negatively stained sample was allowed to dry under natural conditions. For the phageliposome complexes, the samples were examined within 2 hours of the preparation of the complex. The grids were examined under JEOL 2000-FX Intermediate Voltage (200,000 V) scanning TEM.
Fluorescence spectroscopic studies
To estimate the binding constant for liposomes to the engineered phage, UV-Vis and fluorescence spectroscopic studies were carried out by maintaining the liposome concentration constant (1.65 × 10 −11 mol/L of total lipid) and varying the engineered phage concentration from 0 to 30 × 10 −11 mol/L. The fluorescence spectra of the ZnNC-encapsulated liposome and phage-liposome complexes were obtained on a Shimadu RF5301 PC fluorescence spectrophotometer. The excitation wavelength used was 680 nm and the emission was monitored from 700 to 900 nm, keeping the excitation and emission slit widths at 3.0 nm. The fluorescence quantum yields of ZnNC in liposome and phage-liposome complexes (L/P = 2.2) were measured using the ratio method described by the Eaton equation (34, 35) using ZnNC in DMSO as a standard (φ FStandard = 0.07; ref. 36) .
where F Sample and F Standard are the fluorescence intensity of the sample and standard, respectively; A Sample and A Standard are the absorbance of sample and standard, respectively; η Sample and η Standard are the dielectric constant of the solvents used for preparation of sample and standard, respectively. A spectroscopic titration technique was used to determine the binding constant (K b ) of liposome to the engineered phage as per reported procedures (37) . Briefly, the fluorescence intensity of the ZnNC in the liposome was monitored as a function of the concentration of the added phage, exactly after 60 minutes of incubation of the liposome with phage. The intensity of fluorescence was found to increase with increasing concentration of the phage in all the concentrations investigated in this study. The increase fulfills the expression
where F is the fluorescence intensity for a given phage concentration, and 
where [MV 2+ ] is the concentration of the quencher (methyl viologen), F 0 is the fluorescence intensity at [MV 2+ ] = 0, F the fluorescence intensity at a given quencher concentration [MV 2+ ], and K SV is the SternVolmer quenching constant.
Effect of blood plasma on liposome stability
Liposome fractions containing 6-carboxyfluorescein (0.3 mL containing 3 mg total lipid) were mixed with 0.3 mL blood plasma (Innovative Research, Inc.) and incubated for 3 hours at 37°C. Aliquots were diluted 500 times, and the fluorescence (λ ex = 492 nm and λ em = 518 nm) was measured before and after liposome lysis by the addition of 100 μL 10% (w/v) Triton X-100. The percentage of encapsulated carboxyfluorescein was calculated from the expression below (38) . The experiments were repeated in triplicates.
where F i and F t are the fluorescence intensity of the diluted sample before and after lysis using Triton X-100, and F 0 is the fluorescence intensity of the same sample before incubation with blood plasma. The blood plasma stability for the phage-liposome complex (L/P = 6.7) was also estimated through the same procedure. 
Cell cultures
Breast cancer cell lines (SKBR-3) were obtained from the American Type Culture Collection around December 2008. The viability of the cells has been tested and confirmed using trypan blue dye exclusion tests. The cells were initially cultured in 25-cm 2 flasks. On reaching 90% confluence, cells were detached using trypsin/EDTA and centrifuged at 2,000 rpm for 5 minutes. The supernatant was removed and a pellet was resuspended in 5 mL of McCoy's medium. Later, 100 μL of the cell sample were taken and treated with trypan blue, and the viability was verified using a hemocytometer. A human head and neck squamous cell carcinoma
MTT assay
An important prerequisite that a photosensitizer should have is the absence of toxicity, or low toxicity, when not irradiated. Toxicity measurements were carried out on SKBR-3 (3.6 × 10 3 ) and SCC-15 (2.9 × 10 3 ) cells plated onto 24-well plates and treated with 5 μmol/L ZnNC encapsulated in liposomes, engineered phages, and phage-liposome complexes (termed lipoctaglu) carrying 5 μmol/L ZnNC. Untreated cells served as control. Special care was taken to carry out all experiments in dark conditions to avoid the influence of any stray light. After 6 hours of incubation in the dark, the percentage of viable cells in each sample was measured. For this, 0.5 mL MTT (0.5 mg/mL) was added into each well and samples were incubated for 3 hours at 37°C. The MTT crystals formed on incubation were dissolved in 1 mL of HCl (0.04 mol/L) in isopropyl alcohol. The absorbance of the samples were read at 595 nm and subtracted from a reference wavelength of 620 nm in a Shimadzu UV-Vis spectrophotometer (Abs sample ). Similarly, the absorbance of untreated cells were also measured (Abs control ). Data were collected in triplicate. The dark toxicity/toxicity was calculated as follows (39) :
ZnNC (5 μmol/L)-encapsulated liposomes and Lipoctglu containing 5 μmol/L ZnNC was used to study the amount of ZnNC taken up by cells over an incubation period of 12 hours. To calculate intracellular ZnNC concentrations (C intra ), we used the concentration of ZnNC within cell suspensions of known cell densities and assumed a cellular volume of 2.3 × 10 −9 mL. The concentration outside the cell was assumed to be the concentration of ZnNC in 3% PBS (C extra ). The ratio of these two values is indicative of the tendency of ZnNC to be taken up by the cells.
Fluorescence microscopy studies
Fluorescence-labeled bacteriophages and liposomes were prepared according to previously reported procedures (41) . Briefly, rhodamine B labeling of engineered phages were done by mixing 0.2 g of the EDC coupling agent and 0.02 g of rhodamine B in 25 mL of engineered phage stock solution in phosphate buffer (pH 5.6). This procedure results in permanent attachment of the dye through EDC-assisted caging. The labeled phages were extensively dialyzed for 5 days with stirring to remove low molecular weight organic compounds and free dye molecules. The modified phages were stored at 4°C in the dark. Carboxyfluorescein (CF)-labeled liposomes were prepared by replacing 1% of DOPE with DOPE-CF in the preparation of liposomes. The labeled phage and liposomes were allowed to interact in a similar manner as that of engineered phage and ZnNC-liposomes such that the L/P ratio was 6.7. Two sets of six-well tissue culture plates carrying 25-mm coverslips were seeded with 3.5 × 10 3 SKBR-3 and SCC-15 cells. After allowing 24 hours for the cells to attach and spread on the coverslips, unattached cells were removed by washing with PBS (pH 7.4). The cells were then treated with culture medium containing 500 μL of carboxyfluorescein-labeled liposomes and fluorescent lip-octaglu for 3 hours. Treatment was terminated by washing with PBS three times and then fixed by incubating with 4% paraformaldehyde in PBS for 15 minutes, then washed with PBS several times. The cells were mounted on a microscope slide using gelvatol. The green fluorescence associated with carboxyfluorescein-associated cell cultures were examined using a blue filter, and the red fluorescence of rhodamine B was examined using a green filter on a Zeiss Universal epiflourescence microscope with Olympus oil immersion DApo UV objectives. Digital images of cells were collected using Olympus DP-70 camera and software.
Photodynamic therapy
At 30 minutes after treatment of SKBR-3 cells (5 × 10 3 ) with liposome-ZnNC or lip-octaglu, the cells were exposed to near-IR radiation for 4 minutes. External irradiation of the cells was done through a fiber-optic cable capable of delivering laser power at a fluence rate of 206 mW/cm 2 . The cells were incubated for 3 hours following irradiation. The percentage of cell death was calculated using the MTT assay as described above. Trypan blue exclusion studies were carried out by staining the cells with 0.4% trypan blue. Cell viability was observed under a light microscope.
Results and Discussion
Optical properties of phage-liposome complexes
The entrapment of ZnNC in liposomes did not introduce any additional band in the spectra of ZnNC ( Supplementary Fig. S1 ), indicating that the liposome environment did not have an influence on the electronic structure of ZnNC. In addition, the Soret band at 337 nm did not undergo any red shift or split (Supplementary Fig. S1 ), implying the absence of aggregation of ZnNC in liposomes (42) . Residual chloroform was not detectable in the final liposomal composition. The percentage of encapsulation of ZnNC in liposomes was estimated to be 68.9% after disruption of the liposomes in absolute ethanol. The absorption spectra of liposomes and phage-liposome complexes show that the formation of phage-liposome complex did not change the absorption spectra ( Supplementary Fig. S1 ), indicating that ZnNC is not aggregated inside the bilayers of the liposomes. However, the fluorescence intensity of ZnNC is increased on increasing phage concentration (Fig. 2) , indicating that the phage-liposome complex protects ZnNC from water molecules and molecular oxygen that may quench the fluorescence (43) . Quenching of ZnNC fluorescence by using methyl viologen (MV 2+ ) was studied through steady-state emission quenching experiments. Stern-Volmer plots (Fig. 3) were constructed from relative integrated fluorescence intensity at 778 nm. ZnNC-encapsulated liposomes, in the presence of MV 2+ at 25°C, had no significant quenching. In liposomal systems, MV 2+ is oriented coplanarly to the liposomal surface to maximize contact between the polar and nonpolar parts of quencher and liposome (44) . Lower Stern-Volmer constant (K SV ) values for MV 2+ indicate the incorporation of ZnNC into the bilayer structure toward the inner part of the liposomal structure, which lowers the accessibility of MV 2+ to ZnNC.
Further electrostatic repulsion between cationic liposomes and divalent MV 2+ reduces the accessibility of quencher to ZnNC. In the presence of engineered phage (L/P = 2.2), both liposome and quencher are electrostatically immobilized on the phage surface, which may change the orientation of MV 2+ from parallel to perpendicular to liposomal surface. The K SV value of 350/mol/L observed in this study for the phage-liposome system is similar to the case of ZnPC interacting perpendicularly with 9,10-anthraquinone-2,6-disulfonic acid (AQS − ) through an electron transfer process (15) . This observation suggests that engineered phages can serve as efficient carriers for electron transfer processes. The fluorescence quantum yield of the liposome-entrapped ZnNC in the absence and presence of engineered phage (L/P = 2.2) determined as per standard procedures (36) was found to be 0.072 and 0.076, respectively. An increase in the quantum yield of ZnNC due to the formation of phage-liposome complex can be attributed to radiationless relaxation and resonance energy transfer between engineered phage and ZnNC, making phage-liposome complex an ideal vehicle for phototherapeutics (45) .
The binding constant for ZnNC-encapsulated liposomes onto phage, estimated by a spectroscopic titration technique (46) , was found to be 1.1 × 10 10 /mol/L, with number equivalent binding capacity being 1.48 (Supplementary Fig. S2 ). The binding constant is three orders of magnitude higher than that reported for hexa-and octa-arginines onto anionic liposomes (47) . When the weight ratio of the total lipid to the engineered phage (L/P value) was increased, the ζ potential of the phageliposome mixture changes from negative, to zero, and then to positive (Fig. 4) . The ζ potential change confirms that the anionic phage is being assembled with the cationic liposomes.
Microscopic characterization of phage-liposome complexes
The lipid bilayer thickness was estimated to be around 23 nm (Fig. 5A′) . When the phage (Fig. 5B) is mixed with liposomes at a very low concentration (L/P = 40), very few liposomes are bound to a single phage (Supplementary Fig. S3 ) due to the repulsion between cationic liposomes. At a higher phage concentration (L/P = 10), more liposomes were found to bind to an individual phage (Fig. 5C ), similar to the previously observed "beadson-rod" structure (48, 49) . At L/P = 6.7, several linear beads-on-rod structures were entangled to form a nanoweb (Fig. 5D) . At an even higher phage concentration (L/P = 2.9), short rings or spirals (Fig. 5E) were found where phages wrapped liposomes. The formation of rings or spirals has been suggested in microtubuleliposome complexes owing to the mismatch of charge densities between microtubule and cationic liposomes (49) , and in the DNA-liposome system due to electrostatic interactions (43) . When phage concentration is very high (L/P = 2.0), phages self-assembled into a matrix with liposomes embedded (Fig. 5F ).
Plasma stability of phage-liposome nanowebs and their toxicity to mammalian cells
We entrapped carboxyfluorescein into phage-liposome nanowebs and measured their stability in the presence of plasma. Generally, plasma stability is measured in terms of the percentage of carboxyfluorescein that remains encapsulated within the liposome in the presence of plasma (38) . We observed an 18.2% higher percentage of carboxyfluorescein encapsulation when liposomes were complexed to phage than when liposomes were alone. The enhancement in plasma stability for nanowebs is probably due to the presence of phage, which functions in a similar manner to cholesterol in liposomes (50) . Both liposome and nanoweb carriers of ZnNC did not show any dark toxicity within 6 hours to breast (SKBR-3) and squamous cell carcinoma (SCC-15) cell lines, as determined by the MTT assay for a ZnNC concentration of 5 μmol/L (Fig. 6 ). This could be attributed to the stability of liposomes and nanowebs as well as to shorter side chains in ZnNC (51) . Therefore, the nanowebs formed at L/P = 6.7 were found to be stable in serum and showed no dark cell toxicity.
Internalization of phage-liposome nanowebs in cancer cells
PDT requires that photosensitizers be delivered as close as possible to targeted cells. Because electrostatic repulsion between negatively charged cell surface and anionic delivery vectors hinders cellular uptake, we chose to use phage-liposome nanowebs (L/P = 6.7), which are cationic (Fig. 4) and capable of carrying drug more effectively due to their web-like structure, to deliver ZnNC to two types of cancerous cell lines [i.e., breast cancer (SKBR-3) and squamous cell carcinoma (SCC-15) cell lines]. The cationic nanowebs can be attracted by the negatively charged plasma membrane to increase their uptake potential by cancer cells. The ratio of ZnNC internalized into the cells through liposomes or nanowebs to that outside the cells (C intra /C extra ) was determined by following a previously reported procedure (40) . To calculate the intracellular ZnNC, the concentration of ZnNC that remained within the cell was determined. The extracellular ZnNC was determined from the difference between total ZnNC concentration and that within the cell. It was found that the (C intra /C extra ) was higher for nanowebs than for liposomes alone (8.19 and 5.13 for SCC-15 cell lines, respectively, and 6.13 and 3.95 for SKBR-3 cell lines, respectively). This suggests that formation of nanowebs enhances drug delivery into the cancer cells because liposomes are embedded in the web-like nanostructures. Cell internalization of phage-liposome nanowebs was shown through fluorescence microscopy. For this experiment, ZnNC in the bilayer of liposomes was replaced by a green dye, carboxyfluorescein, to fluorescently label the liposomes, because ZnNC fluorescence is in the near-IR region and is invisible. Engineered phage was fluorescently labeled with a red dye, rhodamine-B, through carbodiimide coupling, and the unbound dye was removed by dialysis (41) . Fluorescently tagged liposomes were complexed with rhodamine-tagged phages to form nanowebs (L/P = 6.7). After the nanowebs were incubated with SKBR-3 cells for 3 hours, the fluorescence images (Fig. 7) show that the red and green fluorescence arise from the same regions within the cells, suggesting that the nanowebs containing both dye-labeled liposomes and phages are now associated with the same cells. Similar observations were also made in the case of SCC-15 cells (Supplementary Fig. S4 ).
Photodynamic destruction of cancer cells by phage-liposome complexes
The ability of the nanowebs to function as an efficient photosensitizer carrier was further shown by PDT studies on SKBR-3 cells. Cells were treated with ZnNCencapsulated liposomes and nanowebs separately and irradiated with a near-IR light at a fluence rate of 206 mW/cm 2 for a period of 4 minutes. A 20% increase in cell death was observed in the case of nanoweb-treated cells when compared with liposome-treated cells (Fig. 8) , indicating that the nanowebs can deliver more drugs into the cells than the liposomes alone. Further evidence showing increased cell death on treatment with nanowebs was obtained from trypan blue exclusion studies (Fig. 9) . The study highlights the ability of phage-liposome nanowebs to serve as a more efficient vehicle than liposomes alone to transport photosensitizers to target cells. It is expected that the cell delivery efficiency will be further enhanced if the tips or side walls of the phage in the nanowebs are engineered to codisplay cell-targeting peptides, which we have selected by phage display technique recently (not shown here). This work is now under way.
In summary, we have studied the morphologic evolution of phage-liposome complexes and evaluated their chemical and biological properties for possible applications in drug delivery. Because phages can be engineered to codisplay cancer-targeting peptides at the tip (by fusion to pIII) and liposome-binding peptides on the side wall (by fusion to pVIII, Scheme S1) and anticancer drugs can be loaded into liposomes, the phage-liposome nanowebs assembled from such cancer-targeting phage and anticancer liposomes will serve as novel carriers that can specifically target the anticancer drugs to the tumors ( Supplementary Fig. S5 ).
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